Search

everythinglearnresearchcommunity

for

Search:↓

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Certain immune cells worsen post-surgery gut paralysis by activating a specific immune response.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Alopecia areata is caused by the immune system attacking hair follicles.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Hair follicles help attract immune cells to the skin during stress.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Biological therapy boosts the immune system to effectively fight melanoma.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Improving nerve and immune interactions may help heal chronic wounds.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

A new hydrogel made from human cells improves wound healing by working with immune cells to promote repair.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

M2 macrophages, a type of immune cell, help in new hair growth on scars by producing growth factors.